As one of the most frequent autoimmune diseases, Sjogren's syndrome (SS) is
characterized by overactive lymphocytic infiltration in the exocrine glands, with ensuing dry …

In addition to the rapid development of immune checkpoint inhibitors, there has also been a
surge in the development of self-assembly immunotherapy drugs. Based on the immune …

Nanomaterials are becoming important tools for vaccine development owing to their tunable
and adaptable nature. Unique properties of nanomaterials afford opportunities to modulate …

Supramolecular polymer chemistry, which closely integrates noncovalent interactions with
polymeric structures, is a promising toolbox for living cell engineering. Here, we report our …

The enhancement of immunotherapy is an emerging direction to develop highly effective
and practical cancer therapeutic methods. Here a triply enhanced immunotherapy drug …

Hypoxia‐activated prodrugs (HAPs) have tremendous clinical potential due to their selective
toxicity toward poorly oxygenated tissues, which is a hallmark of solid tumors. Despite their …

Efficient therapeuic proteins' delivery into mammalian cells and subcellular transport (eg,
fast escape from endolysosomes into cytoplasm) are two key biological barriers that need to …

Vaccines are a promising immunotherapy that awakens the human immune system to inhibit
and eliminate cancer with fewer side effects compared with traditional radiotherapy and …

Immunotherapy with monoclonal antibodies targeting immune checkpoint molecules,
including programmed death-1 (PD-1), PD ligand-1 (PD-L1), and cytotoxic T-lymphocyte …

Cancer immunotherapy is set to emerge as the future of cancer therapy. However, recent
immunotherapy trials in different cancers have yielded sub‐optimal results, with durable …